{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:57:08Z","timestamp":1788195428183,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jbspin.2020.105111","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T12:05:54Z","timestamp":1606910754000},"page":"105111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Long-term effect of TNF inhibitors on radiographic progression in ankylosing spondylitis is associated with time-averaged CRP levels"],"prefix":"10.1016","volume":"88","author":[{"given":"Maria","family":"Konsta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios T.","family":"Sakellariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Rusman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P.","family":"Sfikakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexios","family":"Iliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene E.","family":"van der Horst-Bruinsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2020.105111_bib0150","first-page":"79","article-title":"Ankylosing spondylitis and other spondyloarthropathies","volume":"551","author":"Khan","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jbspin.2020.105111_bib0155","first-page":"7","article-title":"Biologic therapies for spondyloarthritis: what is new?","volume":"422","author":"Baraliakos","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jbspin.2020.105111_bib0160","first-page":"1002","article-title":"The natural course of radiographic progression in ankylosing spondylitis--evidence for major individual variations in a large proportion of patients","volume":"997","author":"Baraliakos","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2020.105111_bib0165","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/art.41206","article-title":"The effect of therapy on radiographic progression in axial spondyloarthritis: a systematic review and meta-analysis","volume":"72","author":"Karmacharya","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2020.105111_bib0170","first-page":"1324","article-title":"Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept","volume":"58","author":"van der Heijde","year":"2008"},{"key":"10.1016\/j.jbspin.2020.105111_bib0175","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/art.23901","article-title":"Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis","volume":"58","author":"van der Heijde","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2020.105111_bib0180","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar2794","article-title":"Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years","volume":"11","author":"van der Heijde","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2020.105111_bib0185","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/rheumatology\/kem166","article-title":"Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab","volume":"46","author":"Baraliakos","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2020.105111_bib0190","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/annrheumdis-2012-203075","article-title":"The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial","volume":"73","author":"Braun","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105111_bib0195","first-page":"5","article-title":"Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis","volume":"710","author":"Baraliakos","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105111_bib0200","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.38070","article-title":"The impact of tumor necrosis factor alpha inhibitors on radiographic progression in ankylosing spondylitis","volume":"65","author":"Haroon","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2020.105111_bib0205","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/art.33465","article-title":"Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis","volume":"64","author":"Poddubnyy","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2020.105111_bib0210","first-page":"9","article-title":"Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study","volume":"52","author":"Ramiro","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105111_bib0215","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3899\/jrheum.160003","article-title":"Serum C-reactive protein levels demonstrate predictive value for radiographic and magnetic resonance imaging outcomes in patients with active ankylosing spondylitis treated with golimumab","volume":"43","author":"Braun","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2020.105111_bib0220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-018-1665-1","article-title":"A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis","volume":"20","author":"Deminger","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2020.105111_bib0225","first-page":"8","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"361","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2020.105111_bib0230","first-page":"9","article-title":"Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system","volume":"127","author":"Creemers","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105111_bib0235","first-page":"23","article-title":"Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study","volume":"518","author":"van Tubergen","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105111_bib0240","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/annrheumdis-2012-201370","article-title":"use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis","volume":"71","author":"Kroon","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105111_bib0245","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/annrheumdis-2014-205178","article-title":"Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort","volume":"73","author":"Ramiro","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105111_bib0250","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/ar4144","article-title":"Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?","volume":"15","author":"Ramiro","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2020.105111_bib0255","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/art.40661","article-title":"Impact of tumor necrosis factor inhibitor versus nonsteroidal antiinflammatory drug treatment on radiographic progression in early ankylosing spondylitis: its relationship to inflammation control during treatment","volume":"71","author":"Park","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2020.105111_bib0260","doi-asserted-by":"crossref","first-page":"e0122693","DOI":"10.1371\/journal.pone.0122693","article-title":"Spinal Radiographic progression in patients with ankylosing spondylitis treated with TNF-alpha blocking therapy: a prospective longitudinal observational cohort study","volume":"10","author":"Maas","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jbspin.2020.105111_bib0265","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1136\/annrheumdis-2016-209209","article-title":"High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the german spondyloarthritis inception cohort","volume":"75","author":"Poddubnyy","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105111_bib0270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/annrheumdis-2017-211544","article-title":"TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort","volume":"77","author":"Molnar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105111_bib0275","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13075-016-0943-z","article-title":"Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis","volume":"18","author":"Bello","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2020.105111_bib0280","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13075-018-1626-8","article-title":"Widespread pain in axial spondyloarthritis: clinical importance and gender differences","volume":"20","author":"Swinnen","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2020.105111_bib0285","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1136\/annrheumdis-2012-201999","article-title":"MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor","volume":"71","author":"Machado","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2020.105111_bib0290","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jbspin.2019.04.006","article-title":"Structural progression in axial spondyloarthritis","volume":"87","author":"Aouad","year":"2020","journal-title":"Joint Bone Spine"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X20302189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X20302189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:26:23Z","timestamp":1761150383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X20302189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1297319X20302189"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2020.105111","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effect of TNF inhibitors on radiographic progression in ankylosing spondylitis is associated with time-averaged CRP levels","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2020.105111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105111"}}